Ligand Pharmaceuticals Incorporated

LGNYZ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jun 16, 2026
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 12, 2026 PRIMARY DOCUMENT
4 Jun 12, 2026 PRIMARY DOCUMENT
144 Jun 12, 2026
144 Jun 11, 2026
144 Jun 10, 2026
144 Jun 10, 2026
144 Jun 10, 2026
4 Jun 9, 2026 PRIMARY DOCUMENT
4 Jun 9, 2026 PRIMARY DOCUMENT
4 Jun 9, 2026 PRIMARY DOCUMENT
4 Jun 9, 2026 PRIMARY DOCUMENT
4 Jun 9, 2026 PRIMARY DOCUMENT
4 Jun 9, 2026 PRIMARY DOCUMENT
8-K Jun 9, 2026 8-K
4 Jun 2, 2026 PRIMARY DOCUMENT
4 May 28, 2026 PRIMARY DOCUMENT
DEFA14A May 18, 2026 DEFA14A
8-K May 18, 2026 8-K
4 May 14, 2026 PRIMARY DOCUMENT
144 May 13, 2026
144 May 12, 2026
10-Q May 8, 2026 10-Q
8-K May 7, 2026 8-K
← Newer Page 2 of 89 · 2214 filings Older →